staurosporine has been researched along with Carcinoma, Papillary in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Goncalves, AP; Maximo, V; Soares, P; Videira, A | 1 |
Gregory-Bass, RC; Liu, D; Matthews, R; Olatinwo, M; Stiles, JK; Thomas, K; Thompson, WE; Tsang, B; Xu, W | 1 |
Baker, JR; Phelps, E; Utsugi, S; Wang, SH | 1 |
3 other study(ies) available for staurosporine and Carcinoma, Papillary
Article | Year |
---|---|
Synergistic growth inhibition of cancer cells harboring the RET/PTC1 oncogene by staurosporine and rotenone involves enhanced cell death.
Topics: Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma; Carcinoma, Papillary; Cell Cycle Checkpoints; Cell Death; Cell Division; Cell Line, Tumor; Cell Proliferation; Drug Synergism; Flow Cytometry; Fluorescent Antibody Technique; Humans; Oncogene Proteins, Fusion; Patched Receptors; Proto-Oncogene Proteins c-ret; Receptors, Cell Surface; Rotenone; Staurosporine; Thyroid Cancer, Papillary; Thyroid Gland; Thyroid Neoplasms | 2011 |
Prohibitin silencing reverses stabilization of mitochondrial integrity and chemoresistance in ovarian cancer cells by increasing their sensitivity to apoptosis.
Topics: Adenoviridae; Antineoplastic Agents; Apoptosis; Blotting, Western; Carcinoma, Endometrioid; Carcinoma, Papillary; Caspase 3; Cell Cycle; Cell Line, Tumor; Cell Survival; Drug Resistance, Neoplasm; Enzyme Inhibitors; Female; G1 Phase; Gene Expression Regulation, Neoplastic; Gene Silencing; Genetic Vectors; Humans; Ki-67 Antigen; Microscopy, Fluorescence; Mitochondria; Ovarian Neoplasms; Ovary; Prohibitins; Recombinant Proteins; Repressor Proteins; Resting Phase, Cell Cycle; RNA, Small Interfering; Staurosporine; Up-Regulation | 2008 |
Susceptibility of thyroid cancer cells to 7-hydroxystaurosporine-induced apoptosis correlates with Bcl-2 protein level.
Topics: Alkaloids; Antineoplastic Agents; Apoptosis; bcl-2-Associated X Protein; Carcinoma, Papillary; Cell Survival; Drug Resistance; Humans; Protein Kinase C; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-bcl-2; Staurosporine; Thyroid Neoplasms; Tumor Cells, Cultured; Vitamin D | 2001 |